Abstract:Background & aims: Ammonia levels predicted hospitalisation in a recent landmark study not accounting for portal hypertension and systemic inflammation severity. We investigated (i) the prognostic value of venous ammonia levels (outcome cohort) for liver-related outcomes while accounting for these factors and (ii) its correlation with key disease-driving mechanisms (biomarker cohort). Methods: (i) The outcome cohort included 549 clinically stable outpatients with evidence of advanced chronic liver disease. (ii) The partly overlapping biomarker cohort comprised 193 individuals, recruited from the prospective Vienna Cirrhosis Study (VICIS: NCT03267615). Results: (i) In the outcome cohort, ammonia increased across clinical stages as well as hepatic venous pressure gradient and United Network for Organ Sharing model for end-stage liver disease (2016) strata and were independently linked with diabetes. Ammonia was associated with liver-related death, even after multivariable adjustment (adjusted hazard ratio [aHR]: 1.05 [95% CI: 1.00-1.10]; p = 0.044). The recently proposed cut-off (≥1.4 × upper limit of normal) was independently predictive of hepatic decompensation (aHR: 2.08 [95% CI: 1.35-3.22]; p <0.001), non-elective liver-related hospitalisation (aHR: 1.86 [95% CI: 1.17-2.95]; p = 0.008), and - in those with decompensated advanced chronic liver disease - acute-on-chronic liver failure (aHR: 1.71 [95% CI: 1.05-2.80]; p = 0.031). (ii) Besides hepatic venous pressure gradient, venous ammonia was correlated with markers of endothelial dysfunction and liver fibrogenesis/matrix remodelling in the biomarker cohort. Conclusions: Venous ammonia predicts hepatic decompensation, non-elective liver-related hospitalisation, acute-on-chronic liver failure, and liver-related death, independently of established prognostic indicators including C-reactive protein and hepatic venous pressure gradient. Although venous ammonia is linked with several key disease-driving mechanisms, its prognostic value is not explained by associated hepatic dysfunction, systemic inflammation, or portal hypertension severity, suggesting direct toxicity. Impact and implications: A recent landmark study linked ammonia levels (a simple blood test) with hospitalisation/death in individuals with clinically stable cirrhosis. Our study extends the prognostic value of venous ammonia to other important liver-related complications. Although venous ammonia is linked with several key disease-driving mechanisms, they do not fully explain its prognostic value. This supports the concept of direct ammonia toxicity and ammonia-lowering drugs as disease-modifying treatment.

The Effect of Suffered from Liver Diseases on Venous Ammonia in Continuous Ambulatory Peritoneal Dialysis Patients

Effect of Mild Hepatic Function Impairment on Venous Ammonia in Continuous Ambulatory Peritoneal Dialysis Patients

Evaluation and analysis of patients with continuous ambulatory peritoneal dialysis

The Effect of Fluid Overload on Serum Albumin in Continuous Ambulatory Peritoneal Dialysis Patients

Serum ammonia is a strong prognostic factor for patients with acute-on-chronic liver failure

Impact of ammonia levels on outcome in clinically stable outpatients with advanced chronic liver disease

Risk factors and outcomes of high peritonitis rate in continuous ambulatory peritoneal dialysis patients: A retrospective study.

THE EFFECT OF AUTOMATED VERSUS CONTINUOUS AMBULATORY PERITONEAL DIALYSIS ON MORTALITY RISK IN CHINA.

Changes in Serum Ammonia Concentration in Cirrhotic Patients with Helicobacter Pylori Infection

Factors Affecting the Levels of Serum Creatinine in Continuous Ambulatory Peritoneal Dialysis Patients

[The Effects of Helicobacter Pylori Infection on Hyperammonaemia and Hepatic Encephalopathy in Cirrhotic Patients].

A Short Term Study of Nutritional Effect of Intraperitoneal Amino Acid in CAPD Patients

Influence of peritoneal transport characteristics on nutritional status and clinical outcome in Chinese diabetic nephropathy patients on peritoneal dialysis.

Affects of daytime and continuous ambulatory peritoneal dialysis on cardiovascular complications in patients with ESRD

Changes of the Peritoneal Membrane Ultrafiltration and Solute Transport Function after Peritonitis Episodes in CAPD Patients

Peripheral arterial disease and its related risk factors in patients on continuous ambulatory peritoneal dialysis

Partial pressure of NH 3 in cirrhotic patients with and without hepatic encephalopathy

Effect of peritoneal dialysis on inflammatory factors,nutritional index and renal function in patients with chronic renal failure

Associations of pulmonary function with serum biomarkers and dialysis adequacy in patients undergoing peritoneal dialysis

Ammonia is associated with liver-related complications and predicts mortality in acute-on-chronic liver failure patients

Chronic Inflammation State,malnutrition and Cardiovascular Disease in Peritoneal Dialysis Patients